Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Genetic sleuthing could crack the case of mysterious cancers

NCT ID NCT07366008

First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 16 times

Summary

This study aims to improve diagnosis and treatment for people with Cancer of Unknown Primary (CUP), where the original tumor site cannot be found. Researchers will use advanced genetic analysis of tumor and blood samples to identify the likely cancer origin. The goal is to see if this information helps doctors choose more effective, personalized treatments and improves survival compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY SITE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akershus University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • Haukeland University Hospital

    Bergen, 5021, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Oslo University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • St Olavs Hospital

    Trondheim, Norway

    Contact Email: •••••@•••••

  • Stavanger University Hospital

    Stavanger, Norway

    Contact Email: •••••@•••••

  • University Hospital of North-Norway

    Tromsø, Norway

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.